Cargando…
Case report on the use of canakinumab for treatment of recurrent fevers and proteinuria in refractory systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a chronic multiorgan autoimmune disease with a wide range of clinical manifestations and a characteristic renal involvement leading to proteinuria. There remains an unmet need in SLE disease management as standard treatments including anti-inflammatory drugs, co...
Autores principales: | Yavari, Kimia, Grisanti, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469244/ https://www.ncbi.nlm.nih.gov/pubmed/37664761 http://dx.doi.org/10.1177/26330040231191141 |
Ejemplares similares
-
Canakinumab as rescue therapy in familial Mediterranean fever refractory to conventional treatment
por: Alpa, Mirella, et al.
Publicado: (2015) -
Cryptococcal endocarditis of native valve in a patient with systemic lupus erythematosus
por: Yavari, Seyedeh Kimia, et al.
Publicado: (2023) -
Treatment of refractory Yao syndrome with canakinumab
por: Brailsford, Caroline J., et al.
Publicado: (2022) -
Low-Level Proteinuria in Systemic Lupus Erythematosus
por: Chedid, Alice, et al.
Publicado: (2020) -
Canakinumab for refractory RA: a case report
por: Marketos, Nikolaos, et al.
Publicado: (2018)